Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins αvβ3 and αvβ5

被引:0
|
作者
A. Hasenburg
D.-C. Fischer
X.-W. Tong
A. Rojas-Martinez
R. H. Kaufman
I. Ramzy
P. Kohlberger
M. Orlowska-Volk
E. Aguilar-Cordova
D. G. Kieback
机构
[1] University Medical Center,Department of Obstetrics and Gynecology 1, Department of Pathology
[2] Baylor College of Medicine,Department of Obstetrics and Gynecology, Department of Pediatrics/Hematology
[3] Harvard Gene Therapy Initiative,Oncology, and Department of Pathology
[4] University Medical Center,Department of Obstetrics and Gynecology
关键词
Recurrent ovarian cancer; thymidine kinase gene therapy; intraperitoneal therapy; CAR; integrins αvβ3 and αvβ5;
D O I
10.1177/107155760200900310
中图分类号
学科分类号
摘要
引用
收藏
页码:174 / 180
页数:6
相关论文
共 50 条
  • [1] Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer:: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5
    Hasenburg, A
    Fischer, DC
    Tong, XW
    Rojas-Martinez, A
    Kaufman, RH
    Ramzy, I
    Kohlberger, P
    Orlowska-Volk, M
    Aguilar-Cordova, E
    Kieback, DG
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2002, 9 (03) : 174 - 180
  • [3] Erratum to: Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cencer: Expression of Coxsackie-Adenovirus Receptor and Integrins αgvβ3 and αgvβ5
    A. Hasenburg
    [J]. The Journal of the Society for Gynecologic Investigation: JSGI, 2003, 10 (1): : 58 - 58
  • [4] Anionic Liposomes Increase the Efficiency of Adenovirus-Mediated Gene Transfer to Coxsackie-Adenovirus Receptor Deficient Cells
    Zhong, Zhirong
    Shi, Sanjun
    Han, Jianfeng
    Zhang, Zhirong
    Sun, Xun
    [J]. MOLECULAR PHARMACEUTICS, 2010, 7 (01) : 105 - 115
  • [5] MECHANISM OF ACTION AND DURATION OF TRANSLATION OF THE THYMIDINE KINASE GENE IN ADENOVIRUS-MEDIATED GENE THERAPY OF OVARIAN CANCER
    Kieback, D. G.
    Romano, A.
    Delvoux, B.
    Ollig, S.
    Fischer, D. C.
    [J]. ANTICANCER RESEARCH, 2008, 28 (5C) : 3347 - 3347
  • [6] In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration
    Tong, XW
    Block, A
    Chen, SH
    Contant, CF
    Agoulnik, I
    Blankenburg, K
    Kaufman, RH
    Woo, SLC
    Kieback, DG
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 61 (02) : 175 - 179
  • [7] Coxsackie adenovirus receptor and ανβ3/ανβ5 integrins in adenovirus gene transfer of rat cochlea
    Venail, F.
    Wang, J.
    Ruel, J.
    Ballana, E.
    Rebillard, G.
    Eybalin, M.
    Arbones, M.
    Bosch, A.
    Puel, J-L
    [J]. GENE THERAPY, 2007, 14 (01) : 30 - 37
  • [8] Coxsackie adenovirus receptor and ανβ3/ανβ5 integrins in adenovirus gene transfer of rat cochlea
    F Venail
    J Wang
    J Ruel
    E Ballana
    G Rebillard
    M Eybalin
    M Arbones
    A Bosch
    J-L Puel
    [J]. Gene Therapy, 2007, 14 : 30 - 37
  • [9] Human coxsackie-adenovirus receptor is colocalized with integrins αvβ3 and αvβ5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy -: Implications for cardiotropic viral infections
    Noutsias, M
    Fechner, H
    de Jonge, H
    Wang, XM
    Dekkers, D
    Houtsmuller, AB
    Pauschinger, M
    Bergelson, J
    Warraich, R
    Yacoub, M
    Hetzer, R
    Lamers, J
    Schultheiss, HP
    Poller, W
    [J]. CIRCULATION, 2001, 104 (03) : 275 - 280
  • [10] Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and αvβ5 integrin expression
    Richardson, C
    Brennan, P
    Powell, M
    Prince, S
    Chen, YH
    Spiller, OB
    Rowe, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1669 - 1679